STRO vs TM
Sutro Biopharma (STRO) versus Toyota Motor Corporation ADR (TM) — a side-by-side from cached financials, not a winner call.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Toyota Motor Corporation ADR (TM) is a auto manufacturers company listed on NYSE.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
Latest reported TM revenue for 2013-03-31 was $234.60B. Net income was $10.23B. Revenue was up 3.8% from 2012-03-31 to 2013-03-31. TM currently screens at market cap $211.00B and trailing P/E 9.7.
STRO currently screens at market cap $470.8M. TM currently screens at market cap $211.00B and trailing P/E 9.7.
Not investment advice. Open the STRO and TM stock pages for the full models.
Not investment advice.